Patents by Inventor Peter Lockey

Peter Lockey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLOSING AND OPENING SYSTEMS, AND TEAR TAPE OPENING SYSTEMS
    Publication number: 20180118407
    Abstract: Disclosed herein are tape opening systems, containers, and methods to produce display-ready containers formed of paper-based substrates. The clean tear openings of the disclosed containers are accomplished through novel incorporations of monoaxiaily oriented films with directional tear properties. Also disclosed are closure and opening systems for multi-wall and polywoven pinch bottom open mouth bags using same monoaxially tearable films.
    Type: Application
    Filed: October 26, 2017
    Publication date: May 3, 2018
    Inventors: Jorge A. Nash, William W. Maness, Cynthia A. Stewart-Irvin, Asuka Westbrook, Justine Hanlon, Peter Lockey
  • Combination steroid and glucocorticoid receptor antagonist therapy
    Patent number: 8829024
    Abstract: The present invention provides compositions of an anti-inflammatory glucocorticosteroid and a glucocorticoid receptor (GR) modulator useful for inhibiting glucocorticoid receptor induced transactivation without substantially inhibiting glucocorticoid receptor induced transrepression. Also provided are methods of treating a disorder or condition and reducing the side effects of glucocorticosteroid treatment, using the compositions of the present invention.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: September 9, 2014
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Joe Belanoff, Peter Lockey
  • COMBINATION STEROID AND GLUCOCORTICOID RECEPTOR ANTAGONIST THERAPY
    Publication number: 20130012486
    Abstract: The present invention provides compositions of an anti-inflammatory glucocorticosteroid and a glucocorticoid receptor (GR) modulator useful for inhibiting glucocorticoid receptor induced transactivation without substantially inhibiting glucocorticoid receptor induced transrepression. Also provided are methods of treating a disorder or condition and reducing the side effects of glucocorticosteroid treatment, using the compositions of the present invention.
    Type: Application
    Filed: January 6, 2012
    Publication date: January 10, 2013
    Applicant: Corcept Therapeutics, Inc. (019904)
    Inventors: Joe Belanoff, Peter Lockey